ESSA Pharma Inc.
EPIX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $75,461 | $70,134 | $79,415 | $268,859 |
| - Cash | $85,953 | $86,308 | $93,311 | $103,710 |
| + Debt | $0 | $280 | $305 | $329 |
| Enterprise Value | -$10,492 | -$15,894 | -$13,590 | $165,478 |
| Revenue | $0 | $0 | $0 | $136 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$16 | -$24 | -$23 | $68 |
| % Margin | – | – | – | 50% |
| EBITDA | -$4,980 | -$6,351 | -$8,509 | -$6,332 |
| % Margin | – | – | – | -4,664.6% |
| Net Income | -$4,003 | -$6,375 | -$8,532 | -$6,355 |
| % Margin | – | – | – | -4,681.4% |
| EPS Diluted | -0.09 | -0.14 | -0.19 | -0.14 |
| % Growth | 35.6% | 26.3% | -35.7% | – |
| Operating Cash Flow | -$4,200 | -$6,849 | -$6,470 | -$3,366 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$4,200 | -$6,849 | -$6,470 | -$3,366 |